MX1 - Appendix 4D and Half Year Financial Statements
Filed with ASX · · 26 pages · English
* The Company is only eligible to receive its Research and Development (R&D) Tax Incentive as a cash rebate when it records aggregated annual revenues of less than $20 million. At this point in time, it is uncertain of meeting the revenue requirement and the Company has therefore taken the conservative position that its eligible R&D Tax Incentive be disclosed as a tax loss offset rather than a cas
In the deck
Story so far
Earlier from Micro-X
- MX1 - Response to Publication on Government Website
- MX1 - Head CT First Human Pilot Site at Royal Melbourne
- MX1 - Quarterly Activities Report & Appendix 4C
- MX1 - $6m Capital Raising Presentation
- MX1 - $6.18m Placement
Later from Micro-X
- MX1 - December 2025 Half Year Results Presentation
- MX1 - First Full Body CT Laboratory Test Bench Completed
- $1.3m Checkpoint Contract Extension Awarded by DHS
- MX1 - Human Imaging Study Commences with Micro-X Head CT
- MX1 - Micro-X Completes Full Body CT Critical Design Review
Follow Micro-X into a list and get an email when it puts out news.
Follow Micro-X